Opioid receptor modulator dosage formulations | Patent Number 11229627

US 11229627 B1
Application Number17507091
Publication NumberUS 20220040151 A1
Pendency3 months, 6 days
Filled DateOct 21, 2021
Priority DateMar 14, 2013
Publication DateFeb 10, 2022
Expiration DateMar 13, 2033
Inventor/ApplicantsTim Costello
Jens Jozef Ceulemans
Philip Erna H. Heyns
Eugeen Maria Jozef Jans
ExaminesSTEVENS, MARK V
Art Unit1613
Technology Center1600
Assignments
Abbvie Inc.
Current
Allergan Holdings France S.a.s.Abbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.